Showing results (871-880 of 957) with videos related to

Sort By:
Pageof 96
JAMA Cardiology|August 13, 2025
Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical TrialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2022
Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease ActivityDhruti P Chen, Elizabeth A McInnis, Eveline Y Wu, et al.
Nature Communications|March 16, 2021
Interactions between timing and transmissibility explain diverse flavivirus dynamics in FijiAlasdair D Henderson, Mike Kama, Maite Aubry, et al.
European Journal of Heart Failure|March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy QuestionnaireYasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Nature Microbiology|July 2, 2025
In situ structure of a bacterial flagellar motor at subnanometre resolution reveals adaptations for increased torqueTina Drobnič, Eli J Cohen, Thomas Calcraft, et al.
European Journal of Heart Failure|April 11, 2025
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
European Journal of Heart Failure|March 2, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trialYasuhiro Hamatani, Brian L Claggett, Ian J Kulac, et al.
Pageof 96